Amgen Inc. buy Argus
Start price
27.06.24
/
50%
€291.60
Target price
27.06.25
€317.53
Performance (%)
-18.50%
End price
28.06.25
€237.65
Summary
This prediction ended on 28.06.25 with a price of €237.65. The price of Amgen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.50%. Argus has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €8.81 are taken into consideration when calculating the performance. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 0.963% | 0.963% | 11.662% |
| iShares Core DAX® | -1.338% | -5.619% | 3.378% |
| iShares Nasdaq 100 | -1.067% | 2.598% | 19.132% |
| iShares Nikkei 225® | -1.991% | -6.512% | 27.854% |
| iShares S&P 500 | -1.316% | 0.905% | 14.189% |
Comments by Argus for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Argus from $300.00 to $340.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Argus gewählte maximale Laufzeit wurde überschritten